Cyclothymic disorder

disease
On this page

Also known as affective personality disordercycloid personalitycyclothymiacyclothymic personality

Summary

Cyclothymic disorder (MONDO:0004572) is a disease and 3 clinical trials. A subtype of mood disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namecyclothymic disorder
Mondo IDMONDO:0004572
MeSHD003527
DOIDDOID:845
ICD-10-CMF34.0
ICD-111427638883
SNOMED CT76105009
UMLSC0010598
MedGen1198
Is cancer (heuristic)no

Also known as: affective personality disorder · cycloid personality · cyclothymia · cyclothymic personality

Disease family

This is a subtype of mood disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › psychiatric disordermental disordermood disordercyclothymic disorder

Related subtypes (4): dysthymic disorder, atypical depressive disorder, depressive disorder, bipolar disorder

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified3

Top trials by phase / activity

NCTPhaseStatusTitle
NCT01083823Not specifiedCOMPLETEDCalling for Care: Cell Phones for Mood Telemetry in Teens
NCT01385709Not specifiedCOMPLETEDThe Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
NCT04358900Not specifiedCOMPLETEDUnobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.